Narrow search
Showing 1 - 10 of 35,859
Cover Image
Application of options to the pharmaceutical markets: The solutions of corruption and counterfeit drugs in emerging markets
Wang, Shin-Yun; Hwang, Chih-Chiang - In: International Journal of Accounting and Information … 19 (2011) June, pp. 169-181
counterfeit drugs in emerging markets. Design/methodology/approach – This article proposes a framework for using pharmaceutical …
Persistent link: https://www.econbiz.de/10009188277
Cover Image
Price discrimination by pharmaceutical companies across Central American countries
Rojas, Mariano - In: International Journal of Pharmaceutical and Healthcare … 3 (2009) 2, pp. 118-136
investigation takes advantage of a large database with information about prices of identical drugs sold across Central American …. Findings – Results show that there are significant differences in the prices of identical drugs across the Central American … compared. This investigation uses prices of identical drugs, rather than constructed price indices, to study cross …
Persistent link: https://www.econbiz.de/10014795802
Cover Image
Essential Drugs in Government Healthcare: Emerging Model of Procurement and Supply
N, Lalitha - eSocialSciences - 2009
essential drugs to the government health care which is a positive measure in ensuring `health for all’. [GIDR WP No. 161]. …
Persistent link: https://www.econbiz.de/10004990961
Cover Image
Chapter Three. The Economics of Risky Health Behaviors
Cawley, John; Ruhm, Christopher J. - In: Handbook of health economics : volume 2, (pp. 95-199). 2011
Risky health behaviors such as smoking, drinking alcohol, drug use, unprotected sex, and poor diets and sedentary lifestyles (leading to obesity) are a major source of preventable deaths. This chapter overviews the theoretical frameworks for, and empirical evidence on, the economics of risky...
Persistent link: https://www.econbiz.de/10014025585
Cover Image
Intuition and pharmaceutical research: the case of AstraZeneca
Sundgren, Mats; Styhre, Alexander - In: European Journal of Innovation Management 7 (2004) 4, pp. 267-279
The role of intuition receives little attention in the literature on organizational creativity. This paper describes a study of the role of intuition and its implications for organizational creativity within pharmaceutical research. The study applies French philosopher Bergson's philosophy of...
Persistent link: https://www.econbiz.de/10014721070
Cover Image
For the drugs we need
Rotfeld, Herbert Jack - In: Journal of Consumer Marketing 22 (2005) 7, pp. 365-368
Purpose – To delineate confusions and uncertainties of the issues surrounding those criticisms. Critics assert that all marketing of medical products is abusive, while actual impacts are disputed. Design/methodology/approach – Pulling from past commentaries on pharmaceutical marketing and...
Persistent link: https://www.econbiz.de/10014848491
Cover Image
The order of entry effect in prescription (Rx) and over‐the‐counter (OTC) pharmaceutical drugs
Kalyanaram, Gurumurthy - In: International Journal of Pharmaceutical and Healthcare … 2 (2008) 1, pp. 35-46
‐the‐counter (OTC) pharmaceutical drugs market. Design/methodology/approach – Data on sales, price, direct‐to‐physicians (DTP …) advertising, and direct‐to‐consumers (DTC) advertising for three Rx drugs categories and two OTC drugs categories were obtained … – There is a significant order of entry effect on market share in both Rx and OTC drugs categories. This effect is higher in …
Persistent link: https://www.econbiz.de/10014795776
Cover Image
Off‐label drug use – price analysis for Avastin ® in ophthalmology
Michels, Stephan; Kurz‐Levin, Malaika; Schmitz, Christian - In: International Journal of Pharmaceutical and Healthcare … 3 (2009) 1, pp. 59-73
Purpose – The use of drugs outside the approved indication, called off‐label use, is a growing phenomenon in medical … other comparable drugs approved for the treatment of neovascular AMD. The van Westendorp PSM method found for Avastin used … €90 ($124) and €310 ($428). The discussion provides further implications for pricing strategies for new drugs. Originality …
Persistent link: https://www.econbiz.de/10014795798
Cover Image
“Pressure points” on pharmaceutical industry executives: what lies ahead?
Glass, Harold E.; Poli, Laurence G. - In: International Journal of Pharmaceutical and Healthcare … 3 (2009) 1, pp. 74-83
the industry's future must be accompanied by a concerted effort to communicate and market the importance drugs play in …
Persistent link: https://www.econbiz.de/10014795799
Cover Image
The state of public research on over‐the‐counter drug advertising
DeLorme, Denise E.; Huh, Jisu; Reid, Leonard N.; An, Soontae - In: International Journal of Pharmaceutical and Healthcare … 4 (2010) 3, pp. 208-231
of OTC drug advertising. Findings – Most pharmaceutical advertising studies have focused on prescription drugs, including …
Persistent link: https://www.econbiz.de/10014795830